Back to Journals » Journal of Blood Medicine » Volume 1

Cinryze™ as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety

Total article views   HTML views PDF downloads Totals
20,269 Dovepress* 16,037+ 2,805 18,842
PubMed Central* 4,232 568 4,800
Totals 20,269 3,373 23,642
*Since 24 August 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 0 14

View citations on PubMed Central and Google Scholar